Yawei Qian

499 total citations
17 papers, 361 citations indexed

About

Yawei Qian is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Yawei Qian has authored 17 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Yawei Qian's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Peptidase Inhibition and Analysis (4 papers) and MicroRNA in disease regulation (3 papers). Yawei Qian is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Peptidase Inhibition and Analysis (4 papers) and MicroRNA in disease regulation (3 papers). Yawei Qian collaborates with scholars based in China, Germany and United States. Yawei Qian's co-authors include Wei Yao, Tao Yang, Yan Yang, Jianming Wang, Lei Ji, Weipeng Qi, Qi Shen, Jian Zhang, Jianming Wang and Yan Liu and has published in prestigious journals such as Gastroenterology, Hepatology and Scientific Reports.

In The Last Decade

Yawei Qian

16 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yawei Qian China 9 167 139 98 96 95 17 361
Hideo Tomihara Japan 5 129 0.8× 136 1.0× 60 0.6× 61 0.6× 34 0.4× 23 281
Yen‐Jung Lu Taiwan 13 186 1.1× 167 1.2× 111 1.1× 78 0.8× 28 0.3× 21 416
Binyi Xiao China 13 226 1.4× 125 0.9× 82 0.8× 103 1.1× 46 0.5× 37 391
Yueyun Chen China 9 170 1.0× 71 0.5× 57 0.6× 64 0.7× 62 0.7× 27 301
T. S. Tzai Taiwan 7 143 0.9× 142 1.0× 33 0.3× 153 1.6× 74 0.8× 14 381
Xin‐Gan Qin China 11 96 0.6× 139 1.0× 69 0.7× 84 0.9× 19 0.2× 25 316
Dagui Lin China 8 252 1.5× 130 0.9× 126 1.3× 45 0.5× 112 1.2× 18 428
Yibo Cai China 10 169 1.0× 76 0.5× 34 0.3× 61 0.6× 29 0.3× 19 295
Forn-Chia Lin Taiwan 10 87 0.5× 284 2.0× 234 2.4× 42 0.4× 40 0.4× 13 412
Xiliang Cong China 9 283 1.7× 129 0.9× 112 1.1× 74 0.8× 161 1.7× 14 479

Countries citing papers authored by Yawei Qian

Since Specialization
Citations

This map shows the geographic impact of Yawei Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Qian more than expected).

Fields of papers citing papers by Yawei Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawei Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Qian. The network helps show where Yawei Qian may publish in the future.

Co-authorship network of co-authors of Yawei Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Yawei Qian. A scholar is included among the top collaborators of Yawei Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawei Qian. Yawei Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Yi, Yawei Qian, Yang Liu, et al.. (2024). Bidirectional Mendelian randomization analysis investigating the genetic association between primary breast cancer and colorectal cancer. Frontiers in Immunology. 14. 1260941–1260941. 2 indexed citations
2.
Xu, Peng, Shansong Huang, Jialun Lv, et al.. (2024). N6-methyladenosine-modified MIB1 promotes stemness properties and peritoneal metastasis of gastric cancer cells by ubiquitinating DDX3X. Gastric Cancer. 27(2). 275–291. 4 indexed citations
3.
Xu, Hao, Weizhi Wang, Zhongyuan He, et al.. (2023). Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis. Frontiers in Immunology. 14. 1193614–1193614. 14 indexed citations
4.
Qian, Yawei, Yi Liu, Zichen Wang, et al.. (2023). Investigation of the Causal Relationship Between Alcohol Consumption and COVID-19: A Two-Sample Mendelian Randomization Study. International Journal of Computational Intelligence Systems. 16(1). 2 indexed citations
5.
Huang, Lifeng, Dongwei Xu, Yawei Qian, et al.. (2022). A gene signature is critical for intrahepatic cholangiocarcinoma stem cell self-renewal and chemotherapeutic response. Stem Cell Research & Therapy. 13(1). 292–292. 8 indexed citations
6.
Yang, Tao, Lei Xu, Xiangyü Li, et al.. (2022). Macrophages-aPKCɩ-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 23–23. 42 indexed citations
7.
8.
Qian, Yawei, Guang Zeng, Yue Pan, et al.. (2021). A Prediction Model for High Risk of Positive RT-PCR Test Results in COVID-19 Patients Discharged From Wuhan Leishenshan Hospital, China. Frontiers in Public Health. 9. 778539–778539. 9 indexed citations
9.
He, Yonghan, Wen Li, Junling Zhang, et al.. (2021). The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells. Current Cancer Drug Targets. 21(7). 608–618. 8 indexed citations
10.
Gao, Meng, Yonghua Guo, Peng Xia, et al.. (2021). Loss of FBP1 by aPKC-ι/Snail Pathway-Mediated Repression Promotes Invasion and Aerobic Glycolysis of Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 11. 2 indexed citations
11.
12.
Yang, Tao, et al.. (2019). Prognostic value of periostin in multiple solid cancers: A systematic review with meta‐analysis. Journal of Cellular Physiology. 235(3). 2800–2808. 16 indexed citations
13.
14.
Yao, Wei, Yan Yang, Jianming Wang, et al.. (2017). The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis. Scientific Reports. 7(1). 7525–7525. 110 indexed citations
15.
Qian, Yawei, Wei Yao, Tao Yang, et al.. (2017). aPKC‐ι/P‐Sp1/Snail signaling induces epithelial–mesenchymal transition and immunosuppression in cholangiocarcinoma. Hepatology. 66(4). 1165–1182. 83 indexed citations
16.
Yao, Wei, Jianming Wang, Peter Schemmer, et al.. (2016). TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors. Oncotarget. 7(46). 75441–75456. 29 indexed citations
17.
Yang, Yan, Yan Liu, Jianming Wang, et al.. (2016). 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/snail signaling pathway. Oncotarget. 7(34). 55191–55210. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideo Tomihara Breakdown of academic impact, for papers by Yen‐Jung Lu Breakdown of academic impact, for papers by Binyi Xiao Breakdown of academic impact, for papers by Yueyun Chen Breakdown of academic impact, for papers by T. S. Tzai Breakdown of academic impact, for papers by Xin‐Gan Qin Breakdown of academic impact, for papers by Dagui Lin Breakdown of academic impact, for papers by Yibo Cai Breakdown of academic impact, for papers by Forn-Chia Lin Breakdown of academic impact, for papers by Xiliang Cong
Rankless by CCL
2026